Small Non-cleaved Cell Lymphoma News

Small Non-cleaved Cell Lymphoma	Welcome, Profile Billing Logout

«1 2...2 3 4 5 6 789 10 11 12 13 14 »

||||||||||  Zarnestra (tipifarnib) / Kura Oncology
Trial completion, Metastases:  Tipifarnib in Treating Patients With Advanced Hematologic Cancer (clinicaltrials.gov) -  Feb 19, 2014
P1, N=36, Completed,  Sponsor: National Cancer Institute (NCI)
Suspended --> Completed

||||||||||  topotecan / Generic mfg.
Trial completion:  Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment (clinicaltrials.gov) -  Feb 19, 2014
P2, N=77, Completed,  Sponsor: National Cancer Institute (NCI)
Suspended --> Completed Recruiting --> Completed

||||||||||  NN1213 / Novo Nordisk
Trial completion:  Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (clinicaltrials.gov) -  Feb 19, 2014
P2, N=0, Completed,  Sponsor: Fred Hutchinson Cancer Research Center
Recruiting --> Completed Active, not recruiting --> Completed

||||||||||  azacitidine / Generic mfg., sodium phenylbutyrate / Generic mfg.
Trial completion, Combination therapy, Metastases:  Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment (clinicaltrials.gov) -  Feb 19, 2014
P1, N=0, Completed,  Sponsor: Sidney Kimmel Comprehensive Cancer Center
Active, not recruiting --> Completed Not yet recruiting --> Completed

||||||||||  Zolinza (vorinostat) / Merck (MSD)
Trial completion, Metastases:  Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy (clinicaltrials.gov) -  Feb 19, 2014
P1, N=0, Completed,  Sponsor: Memorial Sloan-Kettering Cancer Center
Not yet recruiting --> Completed Active, not recruiting --> Completed

|||||||||| Trial completion: Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=7, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed

||||||||||  topotecan / Generic mfg., carboplatin / Generic mfg., paclitaxel / Generic mfg.
Trial completion, Combination therapy:  Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma (clinicaltrials.gov) -  Feb 19, 2014
P1, N=17, Completed,  Sponsor: Fox Chase Cancer Center
Active, not recruiting --> Completed Not yet recruiting --> Completed

||||||||||  Vumon (teniposide) / BMS
Trial completion:  Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's Lymphoma (clinicaltrials.gov) -  Feb 19, 2014
P1/2, N=0, Completed,  Sponsor: Northwestern University
Not yet recruiting --> Completed Active, not recruiting --> Completed

||||||||||  Neupogen (filgrastim) / Kyowa Kirin, Amgen, NN1213 / Novo Nordisk
Trial completion, Post-transplantation:  Stem Cell Transplantation in Treating Patients With Hematologic Cancer (clinicaltrials.gov) -  Feb 19, 2014
P1, N=0, Completed,  Sponsor: Northwestern University
Active, not recruiting --> Completed Not yet recruiting --> Completed

||||||||||  cyclophosphamide / Generic mfg.
Trial completion:  Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia (clinicaltrials.gov) -  Feb 19, 2014
P1/2, N=6, Completed,  Sponsor: Northwestern University
Not yet recruiting --> Completed Active, not recruiting --> Completed

||||||||||  tanespimycin (BMS-722782) / BMS
Trial completion, Metastases:  17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma (clinicaltrials.gov) -  Feb 19, 2014
P1, N=60, Completed,  Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Not yet recruiting --> Completed

||||||||||  Neupogen (filgrastim) / Kyowa Kirin, Amgen, NN1213 / Novo Nordisk
Trial completion:  Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (clinicaltrials.gov) -  Feb 19, 2014
P1, N=0, Completed,  Sponsor: Northwestern University
Not yet recruiting --> Completed Not yet recruiting --> Completed

||||||||||  captopril / Generic mfg.
Trial completion:  Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation (clinicaltrials.gov) -  Feb 19, 2014
P3, N=35, Completed,  Sponsor: Northwestern University
Not yet recruiting --> Completed Active, not recruiting --> Completed

||||||||||  Neupogen (filgrastim) / Kyowa Kirin, Amgen
Trial completion, Metastases:  Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer (clinicaltrials.gov) -  Feb 19, 2014
P1, N=40, Completed,  Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Not yet recruiting --> Completed

||||||||||  Neupogen (filgrastim) / Kyowa Kirin, Amgen, Neumega (oprelvekin) / Astellas
Trial completion:  Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors (clinicaltrials.gov) -  Feb 19, 2014
P2, N=0, Completed,  Sponsor: Fred Hutchinson Cancer Research Center
Not yet recruiting --> Completed Active, not recruiting --> Completed

||||||||||  LymphoCide Y-90 (epratuzumab Y-90) / Gilead, Neupogen (filgrastim) / Kyowa Kirin, Amgen
Trial completion:  Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia (clinicaltrials.gov) -  Feb 19, 2014
P1/2, N=18, Completed,  Sponsor: Garden State Cancer Center at the Center for Molecular Medicine and Immunology
Active, not recruiting --> Completed Active, not recruiting --> Completed

||||||||||  Emcyt (estramustine) / Pfizer, Nippon Shinyaku
Trial completion, Metastases:  Combination Chemotherapy in Treating Patients With Advanced Cancer (clinicaltrials.gov) -  Feb 19, 2014
P1/2, N=0, Completed,  Sponsor: New York University School of Medicine
Active, not recruiting --> Completed Active, not recruiting --> Completed

||||||||||  LymphoCide Y-90 (epratuzumab Y-90) / Gilead
Trial completion:  Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia (clinicaltrials.gov) -  Feb 19, 2014
P1/2, N=21, Completed,  Sponsor: Garden State Cancer Center at the Center for Molecular Medicine and Immunology
Active, not recruiting --> Completed Active, not recruiting --> Completed

||||||||||  tanespimycin (BMS-722782) / BMS, NN1213 / Novo Nordisk
Trial completion, Surgery:  17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery (clinicaltrials.gov) -  Feb 19, 2014
P1, N=0, Completed,  Sponsor: Mayo Clinic
Active, not recruiting --> Completed Suspended --> Completed

|||||||||| Trial completion: Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=111, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Suspended --> Completed Active, not recruiting --> Completed

||||||||||  bortezomib / Generic mfg.
Trial completion, Metastases:  PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma (clinicaltrials.gov) -  Feb 19, 2014
P1, N=0, Completed,  Sponsor: New York University School of Medicine
Active, not recruiting --> Completed Not yet recruiting --> Completed

||||||||||  irinotecan / Generic mfg.
Trial completion:  Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma (clinicaltrials.gov) -  Feb 19, 2014
P1, N=60, Completed,  Sponsor: National Cancer Institute (NCI)
Not yet recruiting --> Completed Not yet recruiting --> Completed

||||||||||  Zokinvy (lonafarnib) / Eiger
Trial completion, Metastases:  Combination Chemotherapy in Treating Patients With Advanced Cancer (clinicaltrials.gov) -  Feb 19, 2014
P1, N=25, Completed,  Sponsor: Memorial Sloan-Kettering Cancer Center
Not yet recruiting --> Completed Active, not recruiting --> Completed

||||||||||  Neupogen (filgrastim) / Kyowa Kirin, Amgen, NN1213 / Novo Nordisk
Trial completion:  Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease (clinicaltrials.gov) -  Feb 19, 2014
P2, N=390, Completed,  Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed Active, not recruiting --> Completed

||||||||||  fluconazole oral / Generic mfg., itraconazole / Generic mfg.
Trial completion:  Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation (clinicaltrials.gov) -  Feb 19, 2014
P3, N=578, Completed,  Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed Active, not recruiting --> Completed

||||||||||  NN1213 / Novo Nordisk
Trial completion:  Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer (clinicaltrials.gov) -  Feb 19, 2014
P2, N=3, Completed,  Sponsor: Roswell Park Cancer Institute
Active, not recruiting --> Completed Active, not recruiting --> Completed

||||||||||  Rituxan (rituximab) / Roche
Trial completion:  Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma (clinicaltrials.gov) -  Feb 19, 2014
P3, N=120, Completed,  Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed No longer recruiting --> Completed

|||||||||| Trial completion: Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=38, Completed, Sponsor: Eastern Cooperative Oncology Group
No longer recruiting --> Completed Active, not recruiting --> Completed

||||||||||  irinotecan / Generic mfg.
Trial completion:  Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis (clinicaltrials.gov) -  Feb 19, 2014
P1, N=0, Completed,  Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Not yet recruiting --> Completed

||||||||||  topotecan / Generic mfg., 5-fluorouracil / Generic mfg., leucovorin calcium / Generic mfg.
Trial completion, Combination therapy, Metastases:  Combination Chemotherapy in Treating Patients With Advanced Cancer (clinicaltrials.gov) -  Feb 19, 2014
P1, N=30, Completed,  Sponsor: New York University School of Medicine
Not yet recruiting --> Completed Active, not recruiting --> Completed

||||||||||  Neupogen (filgrastim) / Kyowa Kirin, Amgen
Trial completion, Metastases:  Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer (clinicaltrials.gov) -  Feb 19, 2014
P1, N=24, Completed,  Sponsor: Roswell Park Cancer Institute
Active, not recruiting --> Completed Active, not recruiting --> Completed

|||||||||| Trial completion: Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors (clinicaltrials.gov) - Feb 19, 2014
P2, N=20, Completed, Sponsor: Scripps Health
Active, not recruiting --> Completed Active, not recruiting --> Completed

||||||||||  irinotecan / Generic mfg.
Trial completion:  Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma (clinicaltrials.gov) -  Feb 19, 2014
P2, N=50, Completed,  Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed No longer recruiting --> Completed

||||||||||  vincristine / Generic mfg.
Trial completion:  Bryostatin and Vincristine in B-Cell Malignancies (clinicaltrials.gov) -  Feb 19, 2014
P1, N=18, Completed,  Sponsor: National Cancer Institute (NCI)
No longer recruiting --> Completed Active, not recruiting --> Completed

||||||||||  cyclophosphamide / Generic mfg., busulfan / Generic mfg.
Trial completion:  High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (clinicaltrials.gov) -  Feb 19, 2014
P2, N=66, Completed,  Sponsor: Case Comprehensive Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed

||||||||||  NN1213 / Novo Nordisk
Trial completion:  Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma (clinicaltrials.gov) -  Feb 19, 2014
P2, N=5, Completed,  Sponsor: Case Comprehensive Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed

||||||||||  NN1213 / Novo Nordisk
Trial completion, Metastases:  Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer (clinicaltrials.gov) -  Feb 19, 2014
P1, N=27, Completed,  Sponsor: University of Arizona
Active, not recruiting --> Completed Active, not recruiting --> Completed

||||||||||  decitabine / Generic mfg.
Trial completion, Metastases:  Decitabine in Treating Patients With Melanoma or Other Advanced Cancer (clinicaltrials.gov) -  Feb 19, 2014
P1, N=0, Completed,  Sponsor: California Cancer Consortium
Active, not recruiting --> Completed Not yet recruiting --> Completed

||||||||||  NN1213 / Novo Nordisk
Trial completion:  Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma (clinicaltrials.gov) -  Feb 19, 2014
P1, N=24, Completed,  Sponsor: National Cancer Institute (NCI)
Not yet recruiting --> Completed Not yet recruiting --> Completed

||||||||||  NN1213 / Novo Nordisk
Trial completion:  Perillyl Alcohol in Treating Patients With Refractory Cancer (clinicaltrials.gov) -  Feb 19, 2014
P1, N=25, Completed,  Sponsor: National Cancer Institute (NCI)
Not yet recruiting --> Completed Not yet recruiting --> Completed

||||||||||  phenobarbital / Generic mfg., cyclosporin A microemulsion / Generic mfg., irinotecan / Generic mfg.
Trial completion:  Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma (clinicaltrials.gov) -  Feb 19, 2014
P1, N=3, Completed,  Sponsor: National Cancer Institute (NCI)
Not yet recruiting --> Completed Not yet recruiting --> Completed

||||||||||  Neutrexin (trimetrexate) / Pfizer
Trial completion:  Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma (clinicaltrials.gov) -  Feb 19, 2014
P2, N=25, Completed,  Sponsor: Memorial Sloan-Kettering Cancer Center
Not yet recruiting --> Completed Active, not recruiting --> Completed

||||||||||  NN1213 / Novo Nordisk
Trial completion:  Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation (clinicaltrials.gov) -  Feb 19, 2014
P2, N=30, Completed,  Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed Active, not recruiting --> Completed

|||||||||| Trial completion: Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma (clinicaltrials.gov) - Feb 19, 2014
P2, N=40, Completed, Sponsor: Barbara Ann Karmanos Cancer Institute
Active, not recruiting --> Completed Active, not recruiting --> Completed

|||||||||| Trial completion: Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=46, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed

|||||||||| Trial completion: Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Temple University
Active, not recruiting --> Completed Active, not recruiting --> Completed

||||||||||  Proleukin (aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap, NN1213 / Novo Nordisk
Trial completion, Metastases:  Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer (clinicaltrials.gov) -  Feb 19, 2014
P2, N=0, Completed,  Sponsor: Hoag Memorial Hospital Presbyterian
Active, not recruiting --> Completed Active, not recruiting --> Completed

||||||||||  NN1213 / Novo Nordisk
Trial completion:  Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma (clinicaltrials.gov) -  Feb 19, 2014
P2, N=0, Completed,  Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed

||||||||||  Recentin (cediranib) / AstraZeneca, Avastin (bevacizumab) / Roche
Trial completion, Combination therapy, Metastases:  Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma (clinicaltrials.gov) -  Feb 13, 2014
P1, N=57, Completed,  Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed

||||||||||  cyclophosphamide / Generic mfg.
Trial initiation date:  Pilot Study of Redirected Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia (clinicaltrials.gov) -  Feb 9, 2014
P2, N=20, Recruiting,  Sponsor: National University Health System, Singapore
Active, not recruiting --> Completed Initiation date: Sep 2013 --> Jan 2014



	Diseases Companies Products Productz Mechanisms of Action Sites